Alle verbonden artikelen

New generations of targeted therapies fighting the resistance in solid tumors.

Auteurs : Barthélémy P, Aftimos P, Awada A
Jaar : 2015
Journal : Curr Opin Oncol
Volume : 27(3)
Pagina's : 243-9

What can be learned from our pediatric colleagues?

Auteurs : Klastersky J
Jaar : 2015
Journal : Curr Opin Oncol
Volume : 27
Pagina's : 283-4

Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.

Auteurs : Zardavas D, Piccart-Gebhart M
Jaar : 2015
Journal : Am Soc Clin Oncol Educ Book
Volume : 35
Pagina's : e183-90

Metabolic disorders associated with the use of targeted cancer therapies.

Auteurs : Kotecki N, Penel N, Awada A
Jaar : 2015
Journal : Curr Opin Oncol
Volume : 27(3)
Pagina's : 258-66

Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies.

Auteurs : Gingras I, Azim HA Jr, Ignatiadis M, Sotiriou C
Jaar : 2015
Journal : Clin Adv Hematol Oncol
Volume : 13
Pagina's : 372-82

Tailoring therapies - improving the management of early breast cancer: St GallenInternational Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Auteurs : Coates AS, Winer EP, Goldhirsch A, Gelber Rd, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ
Jaar : 2015
Journal : Ann Oncol
Volume : 26(8)
Pagina's : 1533-46

Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance.

Auteurs : Vouche M, Salem R, Miller FH, Lemort M, Vanderlinden B, De Becker D, Hendlisz A, Flamen P
Jaar : 2015
Journal : Clin Imaging
Volume : 39(3)
Pagina's : 454-62

Neoadjuvant Therapy for Breast Cancer.

Auteurs : Zardavas D, Piccart-Gebhart M
Jaar : 2015
Journal : Annu. Rev. Med.
Volume : 66
Pagina's : 31-48

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

Auteurs : Kalinka-Warzocha E, Plazas JG, Mineur L, Salek T, Hendlisz A, Decosta L, Vogl FD, Passalacqua R
Jaar : 2015
Journal : Gastric Cancer
Volume : 18(2)
Pagina's : 360-7

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.

Auteurs : Machiels JP, Specenier P, Krauß J, Dietz A, Kaminsky MC, Lalami Y, Henke M, Keilholz U, Knecht R, Skartved NJ, Horak ID, Pamperin P, Braun S, Gauler TC
Jaar : 2015
Journal : Cancer Chemother Pharmacol
Volume : 76(1)
Pagina's : 13-20

Ambulatory Outpatient Management of patients with low risk febrile neutropaenia.

Auteurs : Cooksley T, Holland M, Klastersky J
Jaar : 2015
Journal : Acute Med
Volume : 14
Pagina's : 178-81

Pooled analysis of the surgical treatment for colorectal cancer liver metastases.

Auteurs : Veereman G, Robays J, Verleye L, Leroy R, Rolfo C, van Cutsem E, Bielen D, Ceelen W, Danse E, De Man M, Demetter P, Flamen P, Hendlisz A, Sinapi I, Vanbeckevoort D, Ysebaert D, Peeters M
Jaar : 2015
Journal : Crit Rev Oncol Hematol
Volume : 94(1)
Pagina's : 122-135

PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer.

Auteurs : Majewski IJ, Nuciforo P, Mittempergher L, Bosma AJ, Eidtmann H, Holmes E, Sotiriou C, Fumagalli D, Jimenez J, Aura C, Prudkin L, Díaz-Delgado MC, de la Peña L, Loi S, Ellis C, Schultz N, de Azambuja E, Harbeck N, Piccart-Gebhart M, Bernards R, Baselga J
Jaar : 2015
Journal : J. Clin. Oncol.
Volume : 33(12)
Pagina's : 1334-9

Next revolution in molecular theranostics: personalized medicine for urologic cancers.

Auteurs : Aoun F, Kourie HR, Artigas C, Roumeguère T
Jaar : 2015
Journal : Future Oncol
Volume : 11(15)
Pagina's : 2205-19

Clinical management of breast cancer heterogeneity.

Auteurs : Zardavas D, Irrthum A, Swanton C, Piccart-Gebhart M
Jaar : 2015
Journal : Nat Rev Clin Oncol
Volume : 12(7)
Pagina's : 381-94

Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane.

Auteurs : Kaufman PA, Awada A, Twelves C, Yelle L, Perez EA, Velikova G, Olivo MS, He Y, Dutcus CE, Cortes J
Jaar : 2015
Journal : J. Clin. Oncol.
Volume : 33(6)
Pagina's : 594-601

Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015.

Auteurs : Zardavas D, Fouad TM, Piccart-Gebhart M
Jaar : 2015
Journal : Breast
Volume : 24 Suppl 2
Pagina's : S143-8

Aromatase inhibitors in male breast cancer: a pooled analysis.

Auteurs : Zagouri F, Sergentanis TN, Azim HA, Chrysikos D, Dimopoulos MA, Psaltopoulou T
Jaar : 2015
Journal : Breast Cancer Res. Treat.
Volume : 151(1)
Pagina's : 141-7

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.

Auteurs : Strasser-Weippl K, Horick N, Smith IE, O Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE
Jaar : 2015
Journal : Breast Cancer Res
Volume : 17(1)
Pagina's : 56

Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome.

Auteurs : Goldrat O, Kroman N, Peccatori FA, Cordoba O, Pistilli B, Lidegaard O, Demeestere I, Azim HA
Jaar : 2015
Journal : Eur. J. Cancer
Volume : 51(12)
Pagina's : 1490-6